307 related articles for article (PubMed ID: 11232699)
1. Focal neurological signs in hepatic encephalopathy in cirrhotic patients: an underestimated entity?
Cadranel JF; Lebiez E; Di Martino V; Bernard B; El Koury S; Tourbah A; Pidoux B; Valla D; Opolon P
Am J Gastroenterol; 2001 Feb; 96(2):515-8. PubMed ID: 11232699
[TBL] [Abstract][Full Text] [Related]
2. Focal neurological signs in cirrhotic patients with episodes of hepatic encephalopathy.
Kyprianou A; Hanna J; Mullen KD
Am J Gastroenterol; 2001 Feb; 96(2):273-4. PubMed ID: 11232663
[No Abstract] [Full Text] [Related]
3. Subclinical hepatic encephalopathy predicts the development of overt hepatic encephalopathy.
Romero-Gómez M; Boza F; García-Valdecasas MS; García E; Aguilar-Reina J
Am J Gastroenterol; 2001 Sep; 96(9):2718-23. PubMed ID: 11569701
[TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of subclinical hepatic encephalopathy.
Hartmann IJ; Groeneweg M; Quero JC; Beijeman SJ; de Man RA; Hop WC; Schalm SW
Am J Gastroenterol; 2000 Aug; 95(8):2029-34. PubMed ID: 10950053
[TBL] [Abstract][Full Text] [Related]
5. Neurophysiological evidence of cognitive impairment in patients without hepatic encephalopathy after transjugular intrahepatic portosystemic shunts.
Kramer L; Bauer E; Gendo A; Funk G; Madl C; Pidlich J; Gangl A
Am J Gastroenterol; 2002 Jan; 97(1):162-6. PubMed ID: 11808942
[TBL] [Abstract][Full Text] [Related]
6. Sleep disorders and brain MRI as early indicators of subclinical hepatic encephalopathy.
Velissaris D; Solomou E; Kalogeropoulos A; Georgiopoulou V; Thomopoulos C; Karatza C
Hepatogastroenterology; 2006; 53(67):51-4. PubMed ID: 16506375
[TBL] [Abstract][Full Text] [Related]
7. Thyroid function tests in non-alcoholic cirrhotic patients with hepatic encephalopathy.
Güven K; Kelestimur F; Yücesoy M
Eur J Med; 1993 Feb; 2(2):83-5. PubMed ID: 8258022
[TBL] [Abstract][Full Text] [Related]
8. Is it a medical error if we do not screen cirrhotic patients for minimal hepatic encephalopathy?
Quero Guillén JC; Groeneweg M; Jiménez Sáenz M; Schalm SW; Herrerías Gutiérrez JM
Rev Esp Enferm Dig; 2002 Sep; 94(9):544-57. PubMed ID: 12587235
[TBL] [Abstract][Full Text] [Related]
9. MR and 1H MR spectroscopy of the brain in patients with liver cirrhosis and early stages of hepatic encephalopathy.
Tarasów E; Panasiuk A; Siergiejczyk L; Orzechowska-Bobkiewicz A; Lewszuk A; Walecki J; Prokopowicz D
Hepatogastroenterology; 2003; 50(54):2149-53. PubMed ID: 14696484
[TBL] [Abstract][Full Text] [Related]
10. Natural history of minimal hepatic encephalopathy in patients with extrahepatic portal vein obstruction.
Sharma P; Sharma BC; Puri V; Sarin SK
Am J Gastroenterol; 2009 Apr; 104(4):885-90. PubMed ID: 19293781
[TBL] [Abstract][Full Text] [Related]
11. Extrapyramidal signs predict the development of overt hepatic encephalopathy in patients with liver cirrhosis.
Compañy L; Zapater P; Pérez-Mateo M; Jover R
Eur J Gastroenterol Hepatol; 2010 May; 22(5):519-25. PubMed ID: 20010298
[TBL] [Abstract][Full Text] [Related]
12. Chronic parkinsonism associated with cirrhosis: a distinct subset of acquired hepatocerebral degeneration.
Burkhard PR; Delavelle J; Du Pasquier R; Spahr L
Arch Neurol; 2003 Apr; 60(4):521-8. PubMed ID: 12707065
[TBL] [Abstract][Full Text] [Related]
13. Flumazenil therapy for hepatic encephalopathy in cirrhotic patients: a double-blind pragmatic randomized, placebo study.
Cadranel JF; el Younsi M; Pidoux B; Zylberberg P; Benhamou Y; Valla D; Opolon P
Eur J Gastroenterol Hepatol; 1995 Apr; 7(4):325-9. PubMed ID: 7600138
[TBL] [Abstract][Full Text] [Related]
14. Somatosensory evoked potentials and number connection test in the detection of subclinical hepatic encephalopathy.
Yen CL; Liaw YF
Hepatogastroenterology; 1990 Jun; 37(3):332-4. PubMed ID: 2373465
[TBL] [Abstract][Full Text] [Related]
15. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis.
Guevara M; Baccaro ME; Torre A; Gómez-Ansón B; Ríos J; Torres F; Rami L; Monté-Rubio GC; Martín-Llahí M; Arroyo V; Ginès P
Am J Gastroenterol; 2009 Jun; 104(6):1382-9. PubMed ID: 19455124
[TBL] [Abstract][Full Text] [Related]
16. Early detection of hepatic encephalopathy by recording visual evoked potential (VEP).
Zamir D; Storch S; Kovach I; Storch R; Zamir C
Rocz Akad Med Bialymst; 2002; 47():186-93. PubMed ID: 12533959
[TBL] [Abstract][Full Text] [Related]
17. Quantitative evaluation of magnetic resonance imaging (MRI) abnormalities in subclinical hepatic encephalopathy.
Solomou E; Velissaris D; Polychronopoulos P; Kalogeropoulos A; Kiriakopoulou M; Mpadra F; Kordonouri T; Karantza Ch
Hepatogastroenterology; 2005; 52(61):203-7. PubMed ID: 15783031
[TBL] [Abstract][Full Text] [Related]
18. Treatment of cirrhotic hepatic encephalopathy with L-dopa. A controlled trial.
Michel H; Solere M; Granier P; Cauvet G; Bali JP; Pons F; Bellet-Hermann H
Gastroenterology; 1980 Aug; 79(2):207-11. PubMed ID: 6995221
[TBL] [Abstract][Full Text] [Related]
19. [Detection of subclinical and overt hepatic encephalopathy and treatment control after L-ornithine-L-aspartate medication by magnetic resonance spectroscopy ((1)H-MRS)].
Hass HG; Nägele T; Seeger U; Hösl F; Gregor M; Kaiser S
Z Gastroenterol; 2005 Apr; 43(4):373-8. PubMed ID: 15830303
[TBL] [Abstract][Full Text] [Related]
20. [Variability and lengthening of reaction time in the early diagnosis of subclinical hepatic encephalopathy].
Pérez-Cuadrado Martínez E; Silva González C; Robles Reyes A
Rev Esp Enferm Dig; 1990 Jan; 77(1):29-32. PubMed ID: 2334581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
